echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > New way to shrink cancerous tumors through human immune cells

    New way to shrink cancerous tumors through human immune cells

    • Last Update: 2022-05-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The findings are significant because many solid tumor cancers, such as lung cancer, are difficult to treat, the researchers said


    In the new study, the scientists found that altering the metabolism of macrophages, thereby affecting their relationship with T cells, inhibited tumor growth


    "The race to find a cure for cancer never stops," said Stanley Huang, assistant professor of immunology in the School of Medicine's Department of Pathology, who led the study


    The research was recently published in the journal Nature Immunology


    T cells and macrophages

    In general, the body's immune response to disease involves mobilizing white blood cells to attack invaders such as bacteria and bacteria


    Macrophages are specialized white blood cells that engulf invading cells to destroy pathogens


    However, despite their typical protective role, macrophages can be taken up by tumor cells, promoting tumor growth


    Targeting macrophages and PERK proteins

    As tumors grow and macrophages interact with tumor cells, they produce a reactive protein that the study linked to tumor growth


    Professor Huang said the team believes it may be possible to target macrophages and the protein to block tumor growth


    "Knockout of PERK inhibits downstream metabolic signaling in tumor macrophages, resulting in more T cells to fight cancer cells," Huang said


    Research findings and future steps

    The findings suggest that the PERK protein is involved in several key pathways of macrophage metabolism -- when the gene is removed, the macrophages can no longer promote tumor growth; this means the tumors get smaller


    Subsequent experiments further showed that combining the PERK inhibitor drug with an inhibitor called "anti-PD-1" could significantly reduce tumor growth


    Next, the researchers hope to find a clinical drug that inhibits the PERK protein


    "There are several strategies to enhance anti-tumor immunity, such as targeting or editing cellular metabolism," Huang said


    Journal Reference :

    1. Lydia N.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.